|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-10-17
|
|
pubmed:abstractText |
The purpose of this study was to examine the interpatient and intrapatient variability of the Michaelis-Menten plasma parameters of 5-fluorouracil administered according to a schedule combining a bolus of 400 mg/m2 followed by 22-hour infusion of 600 mg/m2 for 2 consecutive days.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0009-9236
|
|
pubmed:author |
pubmed-author:Boisdron-CelleMM,
pubmed-author:BugatRR,
pubmed-author:CanalPP,
pubmed-author:ChatelutEE,
pubmed-author:ErdociainEE,
pubmed-author:Féty-DeporteRR,
pubmed-author:GamelinEE,
pubmed-author:GuimbaudRR,
pubmed-author:LafontTT,
pubmed-author:McLeodH LHL,
pubmed-author:TerretCC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
270-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11014408-Adult,
pubmed-meshheading:11014408-Aged,
pubmed-meshheading:11014408-Antimetabolites, Antineoplastic,
pubmed-meshheading:11014408-Colorectal Neoplasms,
pubmed-meshheading:11014408-Drug Administration Schedule,
pubmed-meshheading:11014408-Drug Interactions,
pubmed-meshheading:11014408-Female,
pubmed-meshheading:11014408-Fluorouracil,
pubmed-meshheading:11014408-Humans,
pubmed-meshheading:11014408-Infusions, Intravenous,
pubmed-meshheading:11014408-Leucovorin,
pubmed-meshheading:11014408-Liver Neoplasms,
pubmed-meshheading:11014408-Male,
pubmed-meshheading:11014408-Middle Aged,
pubmed-meshheading:11014408-Models, Theoretical,
pubmed-meshheading:11014408-Time Factors
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Dose and time dependencies of 5-fluorouracil pharmacokinetics.
|
|
pubmed:affiliation |
Institut Claudius-Regaud and Université Paul-Sabatier, Toulouse, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
